Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
11/2014
11/20/2014US20140343402 Composition Comprising Acetic Anhydride And A Gadolinium Complex, And Method For The Use In Hyperpolarisation In MRI Analysis
11/20/2014US20140341911 Prevention and Treatment of Amyloidogenic Disease
11/20/2014US20140341816 Multiphase oral care compositions
11/20/2014US20140341814 Compounds modulators of vegf activity and uses thereof
11/20/2014US20140341813 Indocyanine green-containing particle and method of producing the particle
11/20/2014US20140341812 Beta-amyloid pet imaging agents
11/20/2014US20140341811 Nanoparticles and Uses Thereof
11/20/2014US20140341810 Antagonists for abdominal vasopressin v2 receptor and uses thereof
11/20/2014US20140341809 High-Affinity DMF5 T Cell Receptor (TCR) Variants
11/20/2014US20140341808 Contrast agent for imagining myocardial perfusion
11/20/2014US20140341802 Provasopressin antagonists and uses thereof
11/18/2014US8890323 Sub-micrometer fluidic channel for measuring photon emitting entities
11/18/2014US8889847 Antibodies and immunoconjugates and uses therefor
11/18/2014US8889839 Pyridine-bis (oxazoline)(“pybox”) moiety as a chelator and sensitizer for lanthanide ion (Ln (III)) Luminescence
11/18/2014US8889430 Nanostructures, methods of synthesizing thereof, and methods of use thereof
11/18/2014US8889425 Means and methods for the determination of camp in vitro and in vivo
11/18/2014US8889362 Cell classification system
11/18/2014US8889153 Combination of immunomodulator and anti-pathogenic agent
11/18/2014US8889103 Diagnostic agent composition and associated methods thereof
11/18/2014US8889102 Neuromyelitis optica autoantibodies as a marker for neoplasia
11/18/2014US8889101 Dendrimer based nanodevices for therapeutic and imaging purposes
11/13/2014US20140336397 Methods for the synthesis of 13c labeled dha and use as a reference standard
11/13/2014US20140335025 Targeting corroles for tumor toxicity and mri
11/13/2014US20140335024 Nanocarriers for imaging and therapy applications
11/13/2014US20140335023 Plasma kallikrein binding proteins
11/13/2014US20140335022 Method for patient selection
11/13/2014US20140335021 Ocular Neostigmine Drops for Diagnosing Myasthenia Gravis
11/13/2014US20140335020 Composition and method of making the novel polymer gel for use in dosimeter
11/13/2014US20140335018 Pharmaceutical composition comprising modified hemoglobin-based therapeutic agent for cancer targeting treatment and diagnostic imaging
11/13/2014US20140335015 Nanoparticles comprising metallic and hafnium oxide materials, preparation and uses thereof
11/13/2014US20140332693 Method of using the novel polymer gel for magnetic resonance imaging (mri) validation
11/11/2014US8884095 Animal models of neurological disorders
11/11/2014US8883977 MUC1 antibody
11/11/2014US8883962 Zinc-responsive peptides, and methods of use thereof
11/11/2014US8883426 Use of therapeutically effective lipids and method for producing organ-/tissue-specific therapeutically effective lipids
11/11/2014US8883124 Use of fullerenes in photoacoustic imaging
11/11/2014US8883123 Use of vaccines for the treatment/prevention of the transmission of pathogens
11/11/2014US8883122 Nanoparticle clusters formed from individual nanoparticles of two or more types
11/11/2014US8883121 Oral preparation useful in measurement capacity to metabolize pyridine
11/06/2014US20140331341 Automated high-content live animal drug screening using c. elegans
11/06/2014US20140331339 Transgenic Non-Human Assay Vertebrates, Assays and Kits
11/06/2014US20140330110 Proton decoupled hyperpolarized magnetic resonance imaging
11/06/2014US20140328851 Cholesterol Ester Transfer Protein (CETP) Inhibitor Polypeptide Antibodies for Prophylactic and Therapeutic Anti-Atherosclerosis Treatments
11/06/2014US20140328830 Anti-integrin beta-1 antibody compositions and methods of use thereof
11/06/2014US20140328768 Iron Oxide Nanocapsule, Method of Manufacturing the Same, and MRI Contrast Agent Using the Same
11/06/2014US20140328767 Method and device for producing optimized lipid-based micro/nano-bubbles
11/06/2014US20140328766 Composition and method for generating a metabolic profile using 13c-mr detection
11/06/2014US20140328765 T1-t2 dual modal mri contrast agents
11/06/2014US20140328764 Biocompatible Nanoparticles with Aggregation Induced Emission Characteristics as Fluorescent Bioprobes and Methods of Using the Same for In Vitro and In Vivo Imaging
11/06/2014US20140328763 Bioactive amphiphilic polymer stabilized nanoparticles with enhanced stability and activity
11/06/2014US20140328761 Local J-Coupling Dye-Zeolite Antenna Composite Materials
11/06/2014US20140328760 Isotopic labeling of higher organisms
11/06/2014US20140328759 Limit size lipid nanoparticles and related methods
11/06/2014US20140328758 Use of fsh receptor ligands for diagnosis and therapy of cancer
11/06/2014US20140328755 Highly selective sigma receptor ligands and radioligands as probes in nociceptive processing and the pathphysiological study of memory deficits and cognitive disorders
11/06/2014US20140328753 Antibodies for Molecular Imaging of Vulnerable Plaques in Atherosclerosis
11/04/2014US8877970 Inhibitors of carbonic anhydrase IX
11/04/2014US8877898 Fluorescent fusion polypeptides and methods of use
11/04/2014US8877483 Dioxin elimination promoter
11/04/2014US8877171 Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis
11/04/2014US8877163 Cycloalkyl triamine pentacarboxylate as ligands for paramagnetic metal complexes
11/04/2014US8877161 GM1-like peptides and uses thereof
11/04/2014US8877160 Phospholipid ether analogs as agents for detecting and locating cancer, and methods thereof
11/04/2014US8877159 Phospholipid analogs as diapeutic agents and methods thereof
11/04/2014US8877158 Targeting agent to newly formed blood vessels
11/04/2014US8877157 N-alkoxyamide conjugates as imaging agents
11/04/2014US8877156 Contrast agents anchored by thiols on nanoparticles
10/2014
10/30/2014US20140325690 Transgenic Non-Human Assay Vertebrates, Assays and Kits
10/30/2014US20140322666 Oral care gel dispenser systems
10/30/2014US20140322326 Particles comprising a releasable dopant therein
10/30/2014US20140322224 Monoclonal antibodies against serotransferrin antigens, and uses therefor
10/30/2014US20140322139 Stabilization of x-ray diagnostic composition
10/30/2014US20140322137 Detection Of Targeted Biological Substances Using Magnetic Relaxation Of Individual Nanoparticles
10/30/2014US20140322136 Methods for treating obesity
10/30/2014US20140322135 Cell therapy for myelodysplastic syndromes
10/30/2014US20140322134 Treatment and Imaging Methods Using Antibodies to Aminophospholipids
10/30/2014US20140322132 Fragments of p97 and uses thereof
10/28/2014US8871995 Method for screening an agent being useful for the treatment of dry eye and/or corneal and conjunctival lesion and pharmaceutical composition obtained by the method
10/28/2014US8871915 Peptides targeting TNF family receptors and antagonizing TNF action, compositions, methods and uses thereof
10/28/2014US8871455 Biomarker panels for assessing radiation injury and exposure
10/28/2014US8871435 Methods and compositions for identifying agents that inhibit an NS4B-mediated neoplastic cellular phenotype of HCV infected cells
10/28/2014US8871310 Surface-modified tantalum oxide nanoparticles, preparation method thereof, and contrast medium for X-ray computed tomography and highly dielectric thin film using same
10/28/2014US8871206 Anti-human folate receptor beta antibodies and methods of use
10/28/2014US8871189 MMP-targeted therapeutic and/or diagnostic nanocarriers
10/28/2014US8871182 3D nanocrystals and manufacturing methods
10/28/2014US8871181 Fluorescent phospholipid ether compounds, compositions, and methods of use
10/28/2014US8871180 Organic-inorganic hybrid particles containing contrast agent
10/28/2014US8870810 Method and apparatus for enhancement of transdermal transport
10/23/2014US20140316255 Raman Imaging Devices and Methods of Molecular Imaging
10/23/2014US20140316246 Chemical exchange saturation transfer angiography
10/23/2014US20140316225 System and method for detecting vascular contamination by surgical anesthetic using non-invasive ir spectrophotometry
10/23/2014US20140316186 Antibodies to tip-1 and grp78
10/23/2014US20140314756 Method for treating psoriasis
10/23/2014US20140314679 Hypoosmotic Solutions for Lymph Node Detection
10/23/2014US20140314678 Compositions and methods using microspheres and non-ionic contrast agents
10/23/2014US20140314677 Substituted silaxanthenium red to near-infrared fluorochromes for in vitro and in vivo imaging and detection
10/23/2014US20140314674 Treatment of cancer with dihydropyrazino-pyrazines
10/23/2014US20140314672 Nanoparticle therapeutic agents, their formulations, and methods of their use
10/23/2014US20140314664 Hydrophobic Molecule-Induced Branched Polymer Aggregates And Their Use
10/23/2014US20140314663 Peptide-mediated delivery of active agents across the blood-brain barrier
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 354